Allogene Therapeutics News

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOORE TIMOTHY L.

Apr 25 04:24

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chang David D

Mar 19 08:16

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Mar 7 10:55

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Arie Belldegrun, M.D.(5.8%),Bellco Legacy IV, LLC(2.8%), etc.

Feb 15 06:33

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-David Chang, M.D., Ph.D.(5.8%),Chang 2006 Family Trust(0.7%), etc.

Feb 15 05:39

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.37%)

Feb 14 06:09

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)

Feb 9 21:40

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOORE TIMOTHY L.

Feb 1 06:58

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Douglas Earl Martin

Feb 1 06:58

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Parker Geoffrey M.

Feb 1 06:54

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Belldegrun Arie

Feb 1 06:54

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Roberts Zachary

Feb 1 06:49

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Chang David D

Feb 1 06:43

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(5.9%)

Jan 30 06:34

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Roberts Zachary

Jan 25 06:31

Allogene Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(1.44%)

Jan 23 13:00

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MESSEMER DEBORAH M.

Dec 21, 2023 05:26

Allogene Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer”)(13.14%)

Oct 26, 2023 05:29

Allogene Therapeutics | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER Parker Geoffrey M.

Oct 18, 2023 05:02

Allogene Therapeutics | 3: Initial statement of beneficial ownership of securities-CHIEF FINANCIAL OFFICER Parker Geoffrey M.

Oct 17, 2023 07:25